Bretaris Genuair

Bretaris Genuair is an inhalation medication containing Aclidinium Bromide, used for managing chronic obstructive pulmonary disease (COPD). This bronchodilator helps improve breathing by relaxing airway muscles.

Bretaris Genuair is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by opening the airways, making it easier to breathe. This medication is not intended for immediate relief of sudden breathing problems but is used regularly to manage symptoms over time.

Common effects of Bretaris Genuair may include dry mouth, throat irritation, and coughing. Some users might experience headaches or dizziness. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

Bretaris Genuair should be used as directed and stored properly to maintain its effectiveness. It is important to follow the prescribed dosage and administration instructions. Patients with certain medical conditions, such as heart problems or glaucoma, should consult a healthcare provider before using this medication.

Bretaris Genuair may interact with other medications, including certain antihistamines and decongestants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be consumed with caution while using this medication.